VERV

Verve Therapeutics
VERV

Overview Fund Activity
Delisted

VERV was delisted on the 24th of July, 2025.

Back to rankings

134 hedge funds and large institutions have $847M invested in Verve Therapeutics in 2023 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 58 increasing their positions, 24 reducing their positions, and 14 closing their positions.

Holders
134
Holders Change
+13
Holders Change %
+10.74%
% of All Funds
2.14%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
27
Increased
58
Reduced
24
Closed
14
Calls
$7M
Puts
$4.99M
Net Calls
+$2M
Net Calls Change
+$1.64M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$64.1M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$33.2M
3
CC
3
Casdin Capital
New York
$39.2M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$87.2M
5
LGM
5
Logos Global Management
California
$2.85M

Top Sellers

1
NHAS
1
Novo Holdings A/S
Denmark
$0
2
APM
2
Avidity Partners Management
Texas
$3.78M
3
Citadel Advisors
3
Citadel Advisors
Florida
$3.15M
4
PHS
4
PFM Health Sciences
California
$0
5
RG
5
Redmile Group
California
$10.7M
Name Market Value Shares Shares
Change 		Shares
Change %
AI
1
Alphabet Inc
California
$140M 10,549,086 – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$87.2M 6,577,562 +531,182 +9%
AIM
3
ARK Investment Management
Florida
$69M 5,200,567 +49,716 +1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$64.1M 4,832,968 +741,753 +18%
BlackRock
5
BlackRock
New York
$53M 3,998,399 +151,696 +4%
State Street
6
State Street
Massachusetts
$43.5M 3,277,180 +214,148 +7%
CC
7
Casdin Capital
New York
$39.2M 2,954,710 +594,139 +25%
Federated Hermes
8
Federated Hermes
Pennsylvania
$33.6M 2,532,369 +129,729 +5%
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
$33.2M 2,505,896 +666,910 +36%
Sumitomo Mitsui Trust Group
10
Sumitomo Mitsui Trust Group
Japan
$28.5M 2,147,243 -38,614 -2%
NAMA
11
Nikko Asset Management Americas
New York
$28.4M 2,147,243 -38,614 -2%
T. Rowe Price Investment Management
12
T. Rowe Price Investment Management
Maryland
$27.9M 2,105,298 +3,937 +0.2%
AVM
13
Arch Venture Management
Illinois
$26.6M 2,008,809 – –
BBA
14
Baker Bros. Advisors
New York
$18.8M 1,416,530 – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$14M 1,052,880 +96,153 +10%
MB
16
MPM BioImpact
Massachusetts
$11.4M 857,940 – –
RG
17
Redmile Group
California
$10.7M 809,777 -252,183 -24%
Wellington Management Group
18
Wellington Management Group
Massachusetts
$10.5M 792,526 -183,602 -19%
BI
19
BVF Inc
California
$8.62M 650,000 – –
WP
20
Woodline Partners
California
$6.91M 521,260 +126,839 +32%
Northern Trust
21
Northern Trust
Illinois
$6.18M 466,322 +8,084 +2%
Charles Schwab
22
Charles Schwab
California
$4.81M 363,044 +27,605 +8%
CAM
23
Cormorant Asset Management
Massachusetts
$4.64M 350,000 – –
Rafferty Asset Management
24
Rafferty Asset Management
New York
$4.24M 319,800 +39,882 +14%
Bank of America
25
Bank of America
North Carolina
$4.17M 314,772 +141,905 +82%
1
2 3 4 5